SLC7A5 and cancer: The classic System L inhibitor, 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH), despite its low affinity and limited selectivity for LAT1, has been shown to inhibit the growth of cancer cells11, 12.